Literature DB >> 25869459

Prostate cancer: MR-TRUS fusion biopsy--defining a new standard.

Eric A Klein1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25869459     DOI： 10.1038/nrclinonc.2015.70

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

1.  Transrectal ultrasound guided prostate biopsy--defining a new standard.

Authors:  E A Klein; C D Zippe
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

2.  Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.

Authors:  Paul F Pinsky; E David Crawford; Barnett S Kramer; Gerald L Andriole; Edward P Gelmann; Robert Grubb; Robert Greenlee; John K Gohagan
Journal:  BJU Int       Date:  2007-01-12       Impact factor: 5.588

3.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Baris Turkbey; Arvin K George; Jason Rothwax; Nabeel Shakir; Chinonyerem Okoro; Dima Raskolnikov; Howard L Parnes; W Marston Linehan; Maria J Merino; Richard M Simon; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

4.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

5.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.

Authors:  Geoffrey A Sonn; Shyam Natarajan; Daniel J A Margolis; Malu MacAiran; Patricia Lieu; Jiaoti Huang; Frederick J Dorey; Leonard S Marks
Journal:  J Urol       Date:  2012-11-14       Impact factor: 7.450

6.  Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.

Authors:  Morgan R Pokorny; Maarten de Rooij; Earl Duncan; Fritz H Schröder; Robert Parkinson; Jelle O Barentsz; Leslie C Thompson
Journal:  Eur Urol       Date:  2014-03-14       Impact factor: 20.096

7.  A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Authors:  Eric A Klein; Matthew R Cooperberg; Cristina Magi-Galluzzi; Jeffry P Simko; Sara M Falzarano; Tara Maddala; June M Chan; Jianbo Li; Janet E Cowan; Athanasios C Tsiatis; Diana B Cherbavaz; Robert J Pelham; Imelda Tenggara-Hunter; Frederick L Baehner; Dejan Knezevic; Phillip G Febbo; Steven Shak; Michael W Kattan; Mark Lee; Peter R Carroll
Journal:  Eur Urol       Date:  2014-05-16       Impact factor: 20.096
  7 in total
  2 in total

1.  Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.

Authors:  Erik Velez; Andriy Fedorov; Kemal Tuncali; Olutayo Olubiyi; Christopher B Allard; Adam S Kibel; Clare M Tempany
Journal:  Abdom Radiol (NY)       Date:  2017-08

Review 2.  Direct magnetic resonance imaging-guided biopsy of the prostate: lessons learned in establishing a regional referral center.

Authors:  Benjamin Addicott; Bryan R Foster; Chenara Johnson; Alice Fung; Christopher L Amling; Fergus V Coakley
Journal:  Transl Androl Urol       Date:  2017-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.